The Food and Drug Administration (FDA) adopted back in June a "Future Framework" scheme that allows Pfizer and Moderna to reformulate and release updated Wuhan coronavirus (COVID-19) [.]
A key federal advisory committee voted Tuesday to recommend emergency authorization of a new COVID-19 vaccine developed by the Maryland biotechnology company Novavax, making it the fourth inoculation against the disease that has killed over 1 million Americans to clear that hurdle in the United States.